Huapont Life Sciences Co Ltd Cash Flow-to-Debt Ratio
Huapont Life Sciences Co Ltd cash flow-to-debt ratio. Huapont Life Sciences Co Ltd (002004) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥635.17 Million could theoretically repay 0% of its total liabilities (CN¥13.15 Billion) in one year. Check 002004 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Huapont Life Sciences Co Ltd (2002–2025)
Cash flow-to-debt ratio of Huapont Life Sciences Co Ltd from 2002 to 2025. Historical debt coverage capacity for Huapont Life Sciences Co Ltd across 24 annual periods. Check cash flow reinvestment rate of Huapont Life Sciences Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Huapont Life Sciences Co Ltd Cash Flow-to-Debt Ratio by Year (2002–2025)
Huapont Life Sciences Co Ltd cash flow-to-debt ratio by year from 2002 to 2025. Year-by-year debt coverage analysis for Huapont Life Sciences Co Ltd. For the full cash flow conversion analysis, see Huapont Life Sciences Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥2.10 Billion | CN¥12.05 Billion | ▲ +49.6% |
| 2024 | 0.12x | CN¥1.63 Billion | CN¥13.98 Billion | ▲ +3.5% |
| 2023 | 0.11x | CN¥1.59 Billion | CN¥14.14 Billion | ▼ -37.1% |
| 2022 | 0.18x | CN¥2.41 Billion | CN¥13.47 Billion | ▲ +100.2% |
| 2021 | 0.09x | CN¥1.27 Billion | CN¥14.22 Billion | ▼ -47.0% |
| 2020 | 0.17x | CN¥2.37 Billion | CN¥14.09 Billion | ▲ +8.3% |
| 2019 | 0.16x | CN¥2.08 Billion | CN¥13.39 Billion | ▲ +12.4% |
| 2018 | 0.14x | CN¥1.91 Billion | CN¥13.80 Billion | ▲ +269.3% |
| 2017 | 0.04x | CN¥591.40 Million | CN¥15.79 Billion | ▼ -1.1% |
| 2016 | 0.04x | CN¥511.90 Million | CN¥13.52 Billion | ▲ +2.8% |
| 2015 | 0.04x | CN¥342.45 Million | CN¥9.30 Billion | ▼ -36.7% |
| 2014 | 0.06x | CN¥455.96 Million | CN¥7.84 Billion | ▼ -39.5% |
| 2013 | 0.10x | CN¥349.51 Million | CN¥3.64 Billion | ▲ +10.6% |
| 2012 | 0.09x | CN¥257.75 Million | CN¥2.97 Billion | ▲ +3.1% |
| 2011 | 0.08x | CN¥135.23 Million | CN¥1.60 Billion | ▼ -65.9% |
| 2010 | 0.25x | CN¥79.84 Million | CN¥322.58 Million | ▼ -50.8% |
| 2009 | 0.50x | CN¥123.53 Million | CN¥245.68 Million | ▲ +43.8% |
| 2008 | 0.35x | CN¥113.76 Million | CN¥325.26 Million | ▲ +58.0% |
| 2007 | 0.22x | CN¥79.21 Million | CN¥357.78 Million | ▼ -18.9% |
| 2006 | 0.27x | CN¥66.10 Million | CN¥242.18 Million | ▼ -76.8% |
| 2005 | 1.18x | CN¥43.69 Million | CN¥37.17 Million | ▲ +32.2% |
| 2004 | 0.89x | CN¥70.60 Million | CN¥79.39 Million | ▲ +25.5% |
| 2003 | 0.71x | CN¥56.68 Million | CN¥79.99 Million | ▲ +101.6% |
| 2002 | 0.35x | CN¥36.88 Million | CN¥104.91 Million | — |